ARMP

Armata Pharmaceuticals, Inc.
CAPPED RATING

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Armata Pharmaceuticals, Inc. (ARMP) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B); its weakest is Momentum (D).

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
B-
Factor Score 2.9 / 5.0
Growth
B
Factor Score 3.2 / 5.0
Profitability
C-
Factor Score 2.1 / 5.0
Momentum
D
Factor Score 1.4 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -1.5
EV / EBITDA -10.5
Rev Growth YoY 173.6%
Gross Margin N/M
Price Return 3M -34.4%
Price Return 12M -53.1%
Catalyst Signal 0.00
Market Cap $111.2M
TTM Revenue $7.6M
Price / Sales 14.7
ROE N/A

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B- (2.9) B (3.2) C- (2.1) D (1.4) C+ (2.6) C (2.4)
2026-11-10 B- (2.9) D+ (1.7) C- (2.1) C- (1.9) C+ (2.6) C (2.2)
2026-11-03 B- (2.9) D+ (1.7) C- (2.1) D (1.3) C+ (2.7) C- (2.1)
2026-10-27 B- (2.9) D+ (1.7) C (2.2) D (1.3) C+ (2.6) C- (2.1)
2026-10-20 B- (2.9) D+ (1.7) C (2.2) D (1.4) C+ (2.6) C (2.2)
Page 1 of 3